Bridging dolutegravir clinical viral response across doses and formulations using model-based exposure-response analysis in pediatrics.

Chandasana H, Hayes S, Buchanan AM, Brothers C, Wiznia A, Bartlett M, Popson S, Townley E, George K, Vavro C, Ruel T, Acosta EP, Singh R, IMPAACT P1093 Team